These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Micromanaging vascular biology: tiny microRNAs play big band. Sen CK; Gordillo GM; Khanna S; Roy S J Vasc Res; 2009; 46(6):527-40. PubMed ID: 19571573 [TBL] [Abstract][Full Text] [Related]
30. microRNA therapeutics in cardiovascular disease models. Dangwal S; Thum T Annu Rev Pharmacol Toxicol; 2014; 54():185-203. PubMed ID: 24111539 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular importance of the microRNA-23/27/24 family. Bang C; Fiedler J; Thum T Microcirculation; 2012 Apr; 19(3):208-14. PubMed ID: 22136461 [TBL] [Abstract][Full Text] [Related]
32. Editorial: Therapeutic Potential of microRNAs in Vascular Disease. Maegdefessel L Curr Vasc Pharmacol; 2015; 13(3):277-9. PubMed ID: 26156263 [TBL] [Abstract][Full Text] [Related]
33. miRNAs: roles and clinical applications in vascular disease. Jamaluddin MS; Weakley SM; Zhang L; Kougias P; Lin PH; Yao Q; Chen C Expert Rev Mol Diagn; 2011 Jan; 11(1):79-89. PubMed ID: 21171923 [TBL] [Abstract][Full Text] [Related]
34. MicroRNAs Mediate Beneficial Effects of Exercise in Heart. Bei Y; Tao L; Cretoiu D; Cretoiu SM; Xiao J Adv Exp Med Biol; 2017; 1000():261-280. PubMed ID: 29098626 [TBL] [Abstract][Full Text] [Related]
35. MiRNAs in peripheral artery disease - something gripping this way comes. Kloos W; Vogel B; Blessing E Vasa; 2014 May; 43(3):163-70. PubMed ID: 24797047 [TBL] [Abstract][Full Text] [Related]
36. Small Molecules with Big Impacts on Cardiovascular Diseases. Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044 [TBL] [Abstract][Full Text] [Related]
37. Unlocking the door to new therapies in cardiovascular disease: microRNAs hold the key. Nguyen MA; Karunakaran D; Rayner KJ Curr Cardiol Rep; 2014 Nov; 16(11):539. PubMed ID: 25303893 [TBL] [Abstract][Full Text] [Related]
38. MicroRNAs: Biomarkers, Diagnostics, and Therapeutics. Huang W Methods Mol Biol; 2017; 1617():57-67. PubMed ID: 28540676 [TBL] [Abstract][Full Text] [Related]
39. Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements. Poller W; Fechner H Curr Pharm Des; 2010; 16(20):2252-68. PubMed ID: 20459390 [TBL] [Abstract][Full Text] [Related]
40. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]